Title: Cellularity Pattern in Induced Sputum in School Aged Asthmatics

Authors: Moustafa M Abdel Raheem, Elham Abdelhady Abdelghany, Emad A Abdel Naem

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i7.169

Abstract

Background:  Many inflammatory phenotypes previously described in adults with asthma: eosinophilic and non-eosinophilic. Treatment strategies based on these phenotypes have been successful. This study tried to evaluate sputum cytology in school aged asthmatics and to classify sputum inflammatory phenotypes in this age group.

Methods:  Complete history, physical examination and asthma control test were performed to all children and adolescents. Pulmonary function tests, CBCs, renal function, sputum induction, processing, homogenization, centrifugation and count were done.

Results: This study included65 children and adolescents with mean age (11.9) 39 mild to moderate asthma (group1) and 26 with severe asthma (group2) according to pre bronchodilator FEV1% (Forced expiratory volume one). Group 1 mean age of was 12.2 ± 2.9 and was 11.43 ± 3.1 for group 2 (p value >0.05). Our study shows eosinophilic phenotype had more uncontrolled (8 patients) and partially controlled patients (7 patients), while only 4 contolled patients had eosinophilic sputum. In neurtrophilic type, most patients were controlled (9 patients) while 3 patients were partially controlled and 3 patients were uncontrolled. Most patients were controlled (8 patients) in paucigranulocytic type while 3 patients were partially controlled and 2 patients were uncontrolled. The last type is mixed in which patients were controlled (10 patients) while 3 patients were partially controlled and 2 patients were uncontrolled. P value is significant as regard level of control

Keywords: asthma phenotypes; induced sputum; children.

References

  1. Mansoli M, Fabian D,Holt S, Beasley R. The global burden of Asthma :executive summary of the GINA Dissemination Committee report. Allergy2004;59:469-78.
  2. Simpson CR, Sheikh A. Trends in epidemiology of the in England:a national study of 333,294 patients. J R Soc Med 2010;103:98-106.
  3. ERS European Respiratory Society 2015. Alexander Moeller, Kai Hakon Carlsen, Peter Sly, Eugenio Baraldi, Giorgio Piacentini, Ian Pavord, Christiane Lex, Sejal Saglani. Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation. European Respiratory Review 2015 24: 204-215;Doc: 10.1183/16000617.00003914
  4. Gibson PG, Grootendor DC, Henry RL, et al. Sputum induction in children. Eur Respir J 2002; 20: Suppl. 37,44s–46s.
  5. Fleming L, Wilson N, Regamey N, et al. Use of sputum eosinophil counts to guide management in children with severe asthma. Thorax 2012; 67: 193–198.
  6. Lex C, Payne DN, Zacharasiewicz A, et al. Sputum induction in children with difficult asthma: safety, feasibility, and inflammatory cell pattern. Pediatr Pulmonol 2005; 39: 318–324.
  7. Bel E, ten BA. A rational approach to the management of severe refractory asthma. Treat Respir Med 2005;4:365–79.
  8. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet  2006;368:804–13.
  9. GINA (2017) Global Initiative for Asthma. Global strategy for asthma management and prevention. Available at http//www.ginasthma.org..
  10. ATS/ERS task force: standardisation of lung function testing’’. EurRespir J 2005; 26: 153–161
  11. Schatz M, Kosinski M, Yarlas AS, Hanlon J,Watson MA, Jhingran P. The minimally important difference of the asthma control test. J Allergy clinimmunol 2009; 124:719-23e1.
  12. Chanez,p., Holz, O., Ind, P,W., Djukanovic´, R., Maestrelli, P.andSterk, P,J. Sputum induction. EurRespir J 2002; 20: Suppl. 37, 3s–8s
  13. Pizzichini, E., Pizzichini, M.M. and Efthimiadis, A.Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid­phase measurements. Am J RespirCrit Care Med 1996;154:308–317.
  14. Fahy, J.V., Wong, H., Liu, J. and Boushey, H.A. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and from healthy subjects. Am J RespirCrit Care Med 1995;152,53-58.
  15. Cleland, W.W. Dithiothreitol, a new protective reagent for SH groups. Biochemistry 1964;3:480–482.
  16. Popov, T., Gottschalk, R., Kolendowicz, R., Dolovich, J., Powers, P. and Hargreave, F.E. The evaluation of a cell dispersion method of sputum examination. ClinExp Allergy 1994;24:778–783
  17. Efthimiadis, A., Weston, S., Carruthers, S., Hussack, P. and Hargreave, F.E. Induced sputum: effect of filtration on the total and differential cell counts. Am J RespirCrit Care Med 2000;161:A853
  18. Louis, R., Shute, J., Goldring, K.& et al. The effect of processing on inflammatory markers in induced sputum. EurRespir J 1999;13:660–667.
  19. Simpson, J.L. , Scott, R.J. , Boyle, M.J. and Gibson, P.G . Inflammatory subtypes in asthma: assessment and identification using induced sputum .Respirology .2006 ; 11 ( 1 ): 54 - 61 .
  20. World Health Organization Asthma. 2017. [Accessed March 7, 2017].
  21. Bierbaum S, Heinzmann A. The genetics of bronchial asthma in children. Respir Med. 2007;101:1369–1375.
  22. Ozdemir C, Ceyhan B, Yazi D, et al. Non-atopic asthma in children is related to maternal bronchial hyper-reactivity. Pediatr Allergy Immunol. 2008;19:248
  23. Lemanske RF, Busse WW. Asthma: clinical expression and molecular mechanisms. J Allergy ClinImmunol 2010;125:S95–S102
  24. Pavord ID, Brightling CE, Woltmann G et al. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999;353: 2213–2214.
  25. Gibson PG, Wlodarczyk JW, Hensley MJ, Gleeson M, Henry RL, Cripps AW et al. Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood. Am J RespirCrit Care Med 1998;58:36–41.
  26. Gibson PG, Simpson JL, Hankin R, Powell H, Henry RL. Relationship between induced sputum eosinophils and the clinical pattern of childhood asthma. Thorax 2003;58:116–121.
  27. SIDRIA (Italian Studies on Respiratory Disorders in Childhood and the Environment). Asthma and respiratory symptoms in 6-7 yr old Italian children: gender, latitude, urbanization and socioeconomic factors. EurRespir J 1997;10:1780–1786.
  28. Lichtenstein P, Svartengren M. Genes, environments, and sex: factors of importance in atopic diseases in 7-9-year-old Swedish twins. Allergy 1997;52:1079–1086.
  29. Nicolai T, Illi S, Tenborg J, Kiess W, von Mutius E. Puberty and prognosis of asthma and bronchial hyper-reactivity. Pediatr Allergy Immunol 2001;12:142–148.
  30. Maziak W, Behrens T, Brasky TM, Duhme H, Rzehak P, Weiland SK et al. Are asthma and allergies in children and adolescents increasing? Results from ISAAC phase I and phase III surveys in Munster Germany Allergy 2003;58:572–579.
  31. Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM et al. A longitudinal, populationbased, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003;349:1414–1422.
  32. Mandhane PJ, Greene JM, Cowan JO, Taylor DR, Sears MR. Sex differences in factors associated with childhoodand adolescent-onset wheeze. Am J RespirCrit Care Med 2005;172:45–54.
  33. Martin AJ, McLennan LA, Landau LI, Phelan PD. The natural history of childhood asthma to adult life. Br Med J 1980;280:1397–1400.
  34. Anderson HR, Pottier AC, Strachan DP. Asthma from birth to age 23: incidence and relation to prior and concurrent atopic disease. Thorax 1992;47:537–542.
  35. Chen Y, Dales R, Tang M, Krewski D. Sex-related interactive effect of smoking and household pets on asthma incidence. EurRespir J 2002;20:1162– 1166.
  36. Henriksen AH, Holmen TL, Bjermer L. Gender differences in asthma prevalence may depend on how asthma is defined. Respir Med 2003;97:491– 497.
  37. Nicolai T, Pereszlenyiova-Bliznakova L, Illi S, Reinhardt D, Von Mutius E. Longitudinal follow-up of the changing gender ratio in asthma from childhood to adulthood: role of delayed manifestation in girls. Pediatr Allergy Immunol 2003;14:280–283.
  38. Singh AK, Cydulka RK, Stahmer SA, Woodruff PG, Camargo CA Jr. Sex differences among adults presenting to the emergency department with acute asthma. Multicenter Asthma Research Collaboration Investigators. Arch Intern Med 1999;159:1237–1243.
  39. Pagtakhan RD, Bjelland JC, Landau LI, Loughlin G, Kaltenborn W, Seeley G et al. Sex differences in growth patterns of the airways and lung parenchyma in children. J ApplPhysiol 1984;56:1204–1210.
  40. Wang F, He XY, Baines KJ, et al. Differentiating inflammatory phenotypes in adults and children with acute asthma. EurResp J. 2011;38:567–574. 
  41. Campo P, Rodríguez F, Sánchez-García S, et al. Phenotypes and endotypes of uncontrolled severe asthma: new treatments. J Investig Allergol ClinImmunol. 2013;23:76–88.
  42. Drews A. C., Pizzichini M. M. M., Pizzichini E., Pereira1 M. U., Pitrez P. M., Jones., ea al. Neutrophilic airway inflammation is a main feature of induced sputum in nonatopic asthmatic children. Allergy 2009: 64: 1597–1601
  43. Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J RespirCrit Care Med. 2008;178:218–224. 
  44. Zietowski Z, Tomasiek-Lozowska MM, Skiepko R, Zietowska E, Bodzenta-Lukaszyk A. Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients. Respir Res. 2010;11:110.
  45. Zacharasiewicz A, Wilson N, Lex C, et al.. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J RespirCrit Care Med 2005;171:1077–82.
  46. Cowan DC,Cowan JO, Palmay R, et al. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax2010;65:384–90.

Corresponding Author

Elham Abdelhady Abdelghany

Department of Chest Diseases and Tuberculosis, Faculty of Medicine, Minia University